Drug Trial Radar · NCT05695950
A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis
Last checked: Nov 19, 2026Latest source record: May 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Feb 27, 2023
Primary completion
Oct 13, 2025
Study completion Apr 20, 2026
Sponsor
- Lead sponsor
- Lakefront Biotherapeutics NVIndustry
- Sponsor type
- Industry
- First posted
- Jan 25, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of orally administered GLPG3667 once daily for 24 weeks in adult participants with dermatomyositis (DM), followed by an open-label extension (OLE) period until Week 48.
Conditions
- Dermatomyositis
Interventions
GLPG3667Drug
GLPG3667 capsules will be administered per dose and schedule specified in the arm description.
PlaceboDrug
Placebo matching to GLPG3667 capsules will be administered per schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total improvement score [TIS] according to the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteriaTime frame: Week 24
Locations
54 sites in 15 countries. Site status is shown where the registry gives one.
HonorHealth Neurology
Scottsdale, Arizona
Inland Rheumatology Clinical Trials, Inc.
Upland, California
New Access Research and Medical Center
Kendall, Florida
Omega Research Orlando, LLC
Orlando, Florida
Augusta University
Augusta, Georgia
St. Paul Rheumatology
Eagan, Minnesota
Northwell Health, LLC PRIME
Lake Success, New York
Altoona Center for Clinical Research, P.C.
Duncansville, Pennsylvania
Fundacion Respirar Consultorios Médicos Dr. Doreski
Buenos Aires, Argentina
Hospital Cordoba
Córdoba, Argentina
Hospital Italiano de La Plata
La Plata, Argentina
Framingham Centro Medico
La Plata, Argentina
Instituto Medico CER
Quilmes, Argentina
UZ Leuven
Leuven, Belgium
Enroll SpA
Santiago, Chile
BioMedica Research Group Psicomedica Clinical and Research Group
Santiago, Chile
Clinica de la Costa S.A.S
Barranquilla, Colombia
Centro de Investigacion Medico Asistencial S.A.S
Barranquilla, Colombia
Healthy Medical Center
Zipaquirá, Colombia
Polyclinic Bonifarm
Zagreb, Croatia
Solmed Polyclinic
Zagreb, Croatia
Revmatologicky Ustav
Prague, Czechia
CHU de Nice Hôpital Pasteur 2 Centre de Réf des Maladies Neuromusculaires et SLA
Nice, France
Groupe Hospitalier Pitie-Salpetriere service de médecine interne et immunologie cliniqu
Paris, France
CHU Strasbourg - Hôpital Hautepierre service de rhumatologie
Strasbourg, France
Charité - Campus Charité Mitte - Klinik für Dermatologie, Venerologie und Allergologie
Berlin, Germany
Helios Fachklinik Vogelsang-Gommern
Gommern, Germany
Universitätsklinikum Tübingen - Universitäts-Hautklinik
Tübingen, Germany
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili) Medicina Interna
Brescia, Italy
Azienda Ospedaliero Universitaria Policlinico. PO San Marco
Catania, Italy
Ospedale San Raffaele U.O. di Medicina Gen. Ind. Immunologico-Clinica
Milan, Italy
Azienda Ospedaliero Universitaria Pisana U.O. Reumatologia Universitaria
Pisa, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy
Istituto Clinico Humanitas U.O. Reumatologia
Rozzano, Italy
Ospedale San Giovanni Bosco
Torino, Italy
Medical Care & Research SA de CV
Mérida, Mexico
Centro de Investigacion Clínica GRAMEL S.C
México, Mexico
Consultorio de Reumatologia Hospital Angeles Lindavista
México, Mexico
Centro de Alta Especialidad en Reumatología e Investigación del Potosí S.C.
San Luis Potosí City, Mexico
Nova Reuma Domysławska i Rusiłowicz, Spółka Partnerska Lekarza Reumatologa i Fizjoterapeuty
Bialystok, Poland
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.